AngioDynamics (ANGO)
(Real Time Quote from BATS)
$5.59 USD
-0.03 (-0.53%)
Updated Jul 10, 2024 03:34 PM ET
4-Sell of 5 4
C Value D Growth B Momentum C VGM
Price, Consensus and EPS Surprise
ANGO 5.59 -0.03(-0.53%)
Will ANGO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ANGO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ANGO
AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval
AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates
ANGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
AngioDynamics (ANGO) Settles Patent Litigations With BD
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
Other News for ANGO
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
Buy Rating on AngioDynamics: Growth and Regulatory Approvals Underscore Positive Outlook
AngioDynamics receives CE Mark approval in Europe for AlphaVac F18������ System
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
AngioDynamics announces CE Mark approval in Europe for AlphaVac F1885